9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice

Atherosclerotic cardiovascular disease is a common and severe complication of diabetes. There is a large need to identify the effective and safety strategies on diabetic cardiovascular disease (DCVD). 9-PAHSA is a novel endogenous fatty acid, and has been reported to reduce blood glucose levels and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yan-Mei Wang, Shou-Ling Mi, Hong Jin, Qi-Lin Guo, Zhong-Yu Yu, Jian-Tao Wang, Xiao-Ming Zhang, Qian Zhang, Na-Na Wang, Yan-Yan Huang, Hou-Guang Zhou, Jing-Chun Guo
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/5d63894a25794b2a80922871f5ba2fea
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5d63894a25794b2a80922871f5ba2fea
record_format dspace
spelling oai:doaj.org-article:5d63894a25794b2a80922871f5ba2fea2021-11-15T06:54:03Z9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice1663-981210.3389/fphar.2021.754387https://doaj.org/article/5d63894a25794b2a80922871f5ba2fea2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.754387/fullhttps://doaj.org/toc/1663-9812Atherosclerotic cardiovascular disease is a common and severe complication of diabetes. There is a large need to identify the effective and safety strategies on diabetic cardiovascular disease (DCVD). 9-PAHSA is a novel endogenous fatty acid, and has been reported to reduce blood glucose levels and attenuate inflammation. We aim to evaluate the effects of 9-PAHSA on DCVD and investigate the possible mechanisms underlying it. Firstly, serum 9-PAHSA levels in human were detected by HPLC-MS/MS analysis. Then 9-PAHSA was synthesized and purified. The synthesized 9-PAHSA was gavaged to db/db mice with 50 mg/kg for 4 weeks. The carotid arterial plaque and cardiac structure was assessed by ultrasound. Cardiac autophagy was tested by western blot analysis, electron microscope and iTRAQ. The results showed that 9-PAHSA, in patients with type 2 diabetes mellitus (T2DM), was significantly lower than that in non-diabetic subjects. Administration of 9-PAHSA for 2 weeks reduced blood glucose levels. Ultrasound observed that continue administration of 9-PAHSA for 4 weeks ameliorated carotid vascular calcification, and attenuated myocardial hypertrophy and dysfunction in db/db mice. Electron microscopy showed continue 9-PAHSA treatment significantly increased autolysosomes, while dramatically decreased greases in the myocardial cells of the db/db mice. Moreover, iTRAQ analysis exhibited that continue 9-PAHSA treatment upregulated BAG3 and HSPB8. Furthermore, western blot analysis confirmed that 9-PAHSA down-regulated Akt/mTOR and activated PI3KIII/BECN1 complex in diabetic myocardium. Thus, 9-PAHSA benefits DCVD in diabetic mice by ameliorating carotid vascular calcification, promoting autophagic flux and reducing myocardial hypertrophy.Yan-Mei WangShou-Ling MiHong JinQi-Lin GuoZhong-Yu YuJian-Tao WangXiao-Ming ZhangQian ZhangNa-Na WangYan-Yan HuangHou-Guang ZhouJing-Chun GuoFrontiers Media S.A.articlediabetic cardiovascular complicationsautophagy9-PAHSAmyocardial hypertrophyvascular calcificationTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic diabetic cardiovascular complications
autophagy
9-PAHSA
myocardial hypertrophy
vascular calcification
Therapeutics. Pharmacology
RM1-950
spellingShingle diabetic cardiovascular complications
autophagy
9-PAHSA
myocardial hypertrophy
vascular calcification
Therapeutics. Pharmacology
RM1-950
Yan-Mei Wang
Shou-Ling Mi
Hong Jin
Qi-Lin Guo
Zhong-Yu Yu
Jian-Tao Wang
Xiao-Ming Zhang
Qian Zhang
Na-Na Wang
Yan-Yan Huang
Hou-Guang Zhou
Jing-Chun Guo
9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice
description Atherosclerotic cardiovascular disease is a common and severe complication of diabetes. There is a large need to identify the effective and safety strategies on diabetic cardiovascular disease (DCVD). 9-PAHSA is a novel endogenous fatty acid, and has been reported to reduce blood glucose levels and attenuate inflammation. We aim to evaluate the effects of 9-PAHSA on DCVD and investigate the possible mechanisms underlying it. Firstly, serum 9-PAHSA levels in human were detected by HPLC-MS/MS analysis. Then 9-PAHSA was synthesized and purified. The synthesized 9-PAHSA was gavaged to db/db mice with 50 mg/kg for 4 weeks. The carotid arterial plaque and cardiac structure was assessed by ultrasound. Cardiac autophagy was tested by western blot analysis, electron microscope and iTRAQ. The results showed that 9-PAHSA, in patients with type 2 diabetes mellitus (T2DM), was significantly lower than that in non-diabetic subjects. Administration of 9-PAHSA for 2 weeks reduced blood glucose levels. Ultrasound observed that continue administration of 9-PAHSA for 4 weeks ameliorated carotid vascular calcification, and attenuated myocardial hypertrophy and dysfunction in db/db mice. Electron microscopy showed continue 9-PAHSA treatment significantly increased autolysosomes, while dramatically decreased greases in the myocardial cells of the db/db mice. Moreover, iTRAQ analysis exhibited that continue 9-PAHSA treatment upregulated BAG3 and HSPB8. Furthermore, western blot analysis confirmed that 9-PAHSA down-regulated Akt/mTOR and activated PI3KIII/BECN1 complex in diabetic myocardium. Thus, 9-PAHSA benefits DCVD in diabetic mice by ameliorating carotid vascular calcification, promoting autophagic flux and reducing myocardial hypertrophy.
format article
author Yan-Mei Wang
Shou-Ling Mi
Hong Jin
Qi-Lin Guo
Zhong-Yu Yu
Jian-Tao Wang
Xiao-Ming Zhang
Qian Zhang
Na-Na Wang
Yan-Yan Huang
Hou-Guang Zhou
Jing-Chun Guo
author_facet Yan-Mei Wang
Shou-Ling Mi
Hong Jin
Qi-Lin Guo
Zhong-Yu Yu
Jian-Tao Wang
Xiao-Ming Zhang
Qian Zhang
Na-Na Wang
Yan-Yan Huang
Hou-Guang Zhou
Jing-Chun Guo
author_sort Yan-Mei Wang
title 9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice
title_short 9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice
title_full 9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice
title_fullStr 9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice
title_full_unstemmed 9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice
title_sort 9-pahsa improves cardiovascular complications by promoting autophagic flux and reducing myocardial hypertrophy in db/db mice
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/5d63894a25794b2a80922871f5ba2fea
work_keys_str_mv AT yanmeiwang 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice
AT shoulingmi 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice
AT hongjin 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice
AT qilinguo 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice
AT zhongyuyu 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice
AT jiantaowang 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice
AT xiaomingzhang 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice
AT qianzhang 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice
AT nanawang 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice
AT yanyanhuang 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice
AT houguangzhou 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice
AT jingchunguo 9pahsaimprovescardiovascularcomplicationsbypromotingautophagicfluxandreducingmyocardialhypertrophyindbdbmice
_version_ 1718428554197204992